Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-08 09:47 am Sale | 2022-03-31 | 13G | CHANNELADVISOR CORP ECOM | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,421,532 4.670% | -674,297 (-32.17%) | Filing History |
| 2022-02-14 09:42 am Purchase | 2021-12-31 | 13G | CYTOKINETICS INC CYTK | DRIEHAUS CAPITAL MANAGEMENT LLC | 2,327,112 2.770% | 2,327,112 (New Position) | Filing History |
| 2022-02-14 09:28 am Purchase | 2021-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | DRIEHAUS CAPITAL MANAGEMENT LLC | 781 5.220% | 781 (New Position) | Filing History |
| 2022-02-14 09:24 am Purchase | 2021-12-31 | 13G | DICE THERAPEUTICS INC DICE | DRIEHAUS CAPITAL MANAGEMENT LLC | 2,146,642 5.610% | 2,146,642 (New Position) | Filing History |
| 2022-02-14 09:19 am Purchase | 2021-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,982,463 8.540% | 1,982,463 (New Position) | Filing History |
| 2022-02-14 09:14 am Purchase | 2021-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | DRIEHAUS CAPITAL MANAGEMENT LLC | 3,123,229 6.050% | 3,123,229 (New Position) | Filing History |
| 2022-01-10 11:09 am Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 4,793,638 10.090% | 4,793,638 (New Position) | Filing History |